Skip to main content
Contact Us
Subscribe
e-Edition
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
58°
Sunny
Site search
Search
Menu
Subscribe
Home
News
Local News
Sports
Obituaries
e-Edition
Classifieds
Real Estate
Property For Rent
Cars & Vehicles
Jobs
Items For Sale
Pets
Auctions, Estate & Garage Sales
Services
Community
Personals
Place An Ad
Explore the Sheyenne
Archives
Best of 2024
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Xenon Pharmaceuticals Inc. - Common Shares
(NQ:
XENE
)
35.18
-0.30 (-0.85%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Mar 13, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Xenon Pharmaceuticals Inc. - Common Shares
< Previous
1
2
3
4
5
6
7
Next >
Xenon to Present at Stifel 2025 Virtual CNS Forum
March 12, 2025
From
Xenon Pharmaceuticals Inc.
Via
GlobeNewswire
Xenon Reports Fourth Quarter & Full Year 2024 Financial Results and Business Update
February 27, 2025
From
Xenon Pharmaceuticals Inc.
Via
GlobeNewswire
Earnings Scheduled For February 27, 2025
February 27, 2025
Via
Benzinga
Xenon to Present at the 45th Annual TD Cowen Healthcare Conference
February 25, 2025
From
Xenon Pharmaceuticals Inc.
Via
GlobeNewswire
Earnings Scheduled For November 12, 2024
November 12, 2024
Via
Benzinga
Earnings Preview: Xenon Pharmaceuticals
November 11, 2024
Via
Benzinga
Xenon to Report Q4 and Full Year 2024 Financial Results on February 27, 2025
February 20, 2025
From
Xenon Pharmaceuticals Inc.
Via
GlobeNewswire
Xenon Outlines Key Corporate Milestone Opportunities for 2025
January 13, 2025
From
Xenon Pharmaceuticals Inc.
Via
GlobeNewswire
Xenon to Present at the 43rd Annual J.P. Morgan Healthcare Conference
January 07, 2025
From
Xenon Pharmaceuticals Inc.
Via
GlobeNewswire
Xenon Showcases New Long-Term Azetukalner Data from X-TOLE OLE Study in FOS at AES 2024
December 06, 2024
From
Xenon Pharmaceuticals Inc.
Via
GlobeNewswire
Xenon to Showcase New Long-Term Azetukalner Data at AES 2024
November 25, 2024
From
Xenon Pharmaceuticals Inc.
Via
GlobeNewswire
Xenon to Present at Upcoming Investor Conferences
November 13, 2024
From
Xenon Pharmaceuticals Inc.
Via
GlobeNewswire
Xenon Reports Q3 2024 Financial Results and Business Update
November 12, 2024
From
Xenon Pharmaceuticals Inc.
Via
GlobeNewswire
Xenon to Report Q3 2024 Financial Results on November 12, 2024
November 05, 2024
From
Xenon Pharmaceuticals Inc.
Via
GlobeNewswire
Xenon to Present at BofA Securities 2024 CNS Therapeutics Virtual Conference
October 02, 2024
From
Xenon Pharmaceuticals Inc.
Via
GlobeNewswire
Xenon Showcases Azetukalner Data at 15th European Epilepsy Congress
September 09, 2024
From
Xenon Pharmaceuticals Inc.
Via
GlobeNewswire
Xenon Expands Leadership Team with Matthew D. Ronsheim, Ph.D. as Chief Operating Officer
August 12, 2024
From
Xenon Pharmaceuticals Inc.
Via
GlobeNewswire
XENE Stock Earnings: Xenon Pharmaceuticals Misses EPS for Q2 2024
August 08, 2024
XENE stock results show that Xenon Pharmaceuticals missed analyst estimates for earnings per share the second quarter of 2024.
Via
InvestorPlace
Xenon Reports Q2 2024 Financial Results and Business Update
August 08, 2024
From
Xenon Pharmaceuticals Inc.
Via
GlobeNewswire
Xenon to Report Q2 2024 Financial Results on August 8, 2024
August 01, 2024
Conference Call and webcast scheduled at 4:30 pm ET
From
Xenon Pharmaceuticals Inc.
Via
GlobeNewswire
Xenon Pharmaceuticals to Present at the Goldman Sachs 45th Annual Global Healthcare Conference
June 05, 2024
From
Xenon Pharmaceuticals Inc.
Via
GlobeNewswire
Xenon Pharmaceuticals Presents Data from Phase 2 X-NOVA Clinical Trial of Azetukalner in Major Depressive Disorder at the American Society of Clinical Psychopharmacology 2024 Annual Meeting
May 28, 2024
From
Xenon Pharmaceuticals Inc.
Via
GlobeNewswire
XENE Stock Earnings: Xenon Pharmaceuticals Beats EPS for Q1 2024
May 09, 2024
XENE stock results show that Xenon Pharmaceuticals beat analyst estimates for earnings per share the first quarter of 2024.
Via
InvestorPlace
Xenon Pharmaceuticals Reports First Quarter 2024 Financial Results and Provides Corporate Update
May 09, 2024
From
Xenon Pharmaceuticals Inc.
Via
GlobeNewswire
Xenon Pharmaceuticals to Present at the BofA Securities Health Care Conference 2024
May 08, 2024
From
Xenon Pharmaceuticals Inc.
Via
GlobeNewswire
Xenon Pharmaceuticals to Present at the 2024 RBC Capital Markets Global Healthcare Conference
May 07, 2024
From
Xenon Pharmaceuticals Inc.
Via
GlobeNewswire
Xenon Pharmaceuticals Announces Conference Call and Webcast to Discuss First Quarter 2024 Financial Results and Provide Corporate Update
May 02, 2024
From
Xenon Pharmaceuticals Inc.
Via
GlobeNewswire
Xenon Pharmaceuticals Showcases XEN1101 at the American Academy of Neurology 2024 Annual Meeting
April 16, 2024
From
Xenon Pharmaceuticals Inc.
Via
GlobeNewswire
Xenon Pharmaceuticals to Present at the 2024 Bloom Burton & Co. Healthcare Investor Conference
April 10, 2024
From
Xenon Pharmaceuticals Inc.
Via
GlobeNewswire
Xenon Pharmaceuticals to Present at the 23rd Annual Needham Virtual Healthcare Conference
April 04, 2024
From
Xenon Pharmaceuticals Inc.
Via
GlobeNewswire
< Previous
1
2
3
4
5
6
7
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.
